射干麻黄汤联合雾化吸入治疗儿童呼吸道感染后慢性咳嗽风寒恋肺证临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R256.11;R441.5

基金项目:

浙江省医药卫生科技计划项目(2023RC056)


Clinical Study on Combination Use of Shegan Mahuang Decoction and Aerosol Inhalation for Chronic Cough with Syndrome of Wind-Cold Stagnation in the Lung After Respiratory Tract Infection in Children
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察采用射干麻黄汤联合雾化吸入治疗儿童呼吸道感染后慢性咳嗽风寒恋肺证的临床疗效。 方法:采取前瞻性对照研究设计法。按随机数字表法将诸暨市第四人民医院儿科收治的104例呼吸道感染后慢 性咳嗽患儿分为观察组与对照组各52例。对照组给予吸入用复方异丙托溴铵溶液联合吸入用布地奈德混悬液 雾化吸入治疗,观察组在对照组治疗方案的基础上加用射干麻黄汤治疗,治疗10 d后评估2组临床疗效、咳嗽 症状(日间/夜间咳嗽症状评分)、炎症指标、细胞免疫功能及安全性。结果:最终观察组完成研究50例(剔除 1例,脱落1例),对照组完成研究48例(剔除3例,脱落1例)。治疗10 d后,2组日间和夜间咳嗽评分均低于 治疗前,且观察组低于对照组,差异均有统计学意义(P<0.05)。2组血清白细胞介素-4(IL-4)、白细胞介 素-6(IL-6)、肿瘤坏死因子-α(TNF-α) 及免疫球蛋白-E(IgE) 水平均低于治疗前,且观察组以上各项指 标水平均低于对照组,差异均有统计学意义(P<0.05);2组血清干扰素-γ(INF-γ) 水平均高于治疗前,且 观察组高于对照组,差异均有统计学意义(P<0.05)。2组T淋巴细胞亚群CD3+、CD4+及CD4+/CD8+比值均高于 治疗前,且观察组以上各项指标均高于对照组,差异均有统计学意义(P<0.05);2组CD8+水平均低于治疗 前,且观察组低于对照组,差异均有统计学意义(P<0.05)。临床疗效总有效率观察组94.00%(47/50),对照 组79.17%(38/48),2组比较,差异有统计学意义(P<0.05)。不良反应发生率观察组4.00%(2/50),对照组 16.67%(8/48),2组比较,差异有统计学意义(P<0.05)。结论:儿童呼吸道感染后慢性咳嗽风寒恋肺证给予 射干麻黄汤联合雾化吸入治疗效果良好,对缓解咳嗽症状、减轻机体炎症反应、调节机体免疫功能及减少不良 反应方面有积极作用。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Shegan Mahuang Decoction and aerosol inhalation on chronic cough with syndrome of wind-cold stagnation in the lung after respiratory tract infection in children. Methods: A prospective controlled study design method was adopted.According to the random number table method,104 children with chronic cough after respiratory tract infection admitted to the Department of Pediatrics of Zhuji Fourth People's Hospital were divided into the observation group and the control group,with 52 cases in each group.The control group was treated with Compound Ipratropium Bromide Solution for Inhalation combined with Budesonide Suspension for Inhalation.The observation group was treated with Shegan Mahuang Decoction on the basis of the treatment plan of the control group.After 10 days of treatment,the clinical efficacy,cough symptoms (daytime/night time cough symptom scores), inflammatory indexes, cellular immune function, and safety in the two groups were evaluated. Results : Finally, 50 cases in the observation group completed the study (excluding 1 case, dropping 1 case),and 48 in the control group (excluding 3 cases,dropping 1 case).After 10 days of treatment,the daytime and nighttime cough scores in the two groups were decreased when compared with those before treatment,and the scores in the observation group were lower than those in the control group, differences being significant (P<0.05). The levels of serum interleukin-4( IL-4),interleukin-6( IL-6),tumor necrosis factor-α( TNF-α),and immunoglobulin E( IgE) in the two groups were decreased when compared with those before treatment, and the levels of the above indexes in the observation group were lower than those in the control group, differences being significant (P<0.05). The levels of serum interferon-γ (INF-γ) in the two groups were increased when compared with those before treatment, and the INF-γ level in the observation group was higher than that in the control group,differences being significant( P<0.05). The CD3+,CD4+,and CD4+/CD8+ ratio of T lymphocyte subsets in the two groups were increased when compared with those before treatment,and the above three indexes in the observation group were higher than those in the control group, differences being significant( P<0.05).The levels of CD8+ in the two groups were decreased when compared with those before treatment, and the CD8+ level in the observation group was lower than that in the control group, differences being significant( P<0.05).The total effective rate was 94.00%( 47/50) in the observation group and 79.17%( 38/48) in the control group,the difference being significant( P<0.05).The incidence of adverse reactions was 4.00%( 2/50) in the observation group and 16.67% (8/48) in the control group, the difference being significant (P<0.05). Conclusion:The combination use of Shegan Mahuang Decoction and aerosol inhalation has a great curative effect on chronic cough with syndrome of wind-cold stagnation in the lung after respiratory tract infection in children,which can play an active role in improving cough symptoms,mitigating inflammatory responses,adjusting immune function,and reducing adverse reactions.

    参考文献
    相似文献
    引证文献
引用本文

温金霞,谢玲玲,朱金燕.射干麻黄汤联合雾化吸入治疗儿童呼吸道感染后慢性咳嗽风寒恋肺证临床研究[J].新中医,2026,58(6):38-44

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-03-31
  • 出版日期:
文章二维码